Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000221766 | SCV000278472 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-04-07 | criteria provided, single submitter | clinical testing | The p.S1094W variant (also known as c.3281C>G), located in coding exon 27 of the TSC2 gene, results from a C to G substitution at nucleotide position 3281. The serine at codon 1094 is replaced by tryptophan, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001341323 | SCV001535191 | benign | Tuberous sclerosis 2 | 2023-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001341323 | SCV002040756 | uncertain significance | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002251447 | SCV002522044 | uncertain significance | not provided | 2023-11-14 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |